K083105 is an FDA 510(k) clearance for the KNEEHAB XP CONDUCTIVE GARMENT, TYPE 411. Classified as Stimulator, Muscle, Powered (product code IPF), Class II - Special Controls.
Submitted by Bio-Medical Research, Ltd. (Galway, IE). The FDA issued a Cleared decision on July 24, 2009 after a review of 277 days - an extended review cycle.
This device falls under the Physical Medicine FDA review panel, regulated under 21 CFR 890.5850 - the FDA physical medicine device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.
Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Physical Medicine review framework, consistent with the majority of Class II 510(k) submissions.
View all Bio-Medical Research, Ltd. devices
NCT00738010
Completed
Interventional
Industry-sponsored
Effectiveness of Kneehab in Strengthening Quadriceps in Rehabilitation Post Anterior Cruciate Ligament (ACL) Reconstruction
The Effectiveness of Kneehab in Strengthening the Quadriceps of Patients in Rehabilitation After Anterior Cruciate Ligament Reconstruction
| Condition studied |
Anterior Cruciate Ligament Reconstruction |
| Study design |
Single group |
| Eligibility |
All sexes
· 18 Years+
|
| Sponsor |
Bio-Medical Research, Ltd.
(industry)
|
Started 2005-04-01
→
Primary completion 2006-10-01
Primary outcome
Isokinetic strength test of extension of the injured leg. Relative strength extension ratio (injured/uninjured). Distance of the jump achieved in the single leg hop and the time to achieve the shuttle run.
Secondary outcome
Strength test of flexors of the knee joint and 5 tests of coordination and proprioception (triple hop; side-step; carioca; timed hop and cross-over hop).
Study completed - no results published.
This trial concluded in 2006 but has not posted
results to ClinicalTrials.gov. Completed studies without public results are common
in industry-sponsored device trials; the data may be referenced in the
510(k) Summary PDF or remain unpublished.
View full study on ClinicalTrials.gov